Literature DB >> 9625323

Importance of hepatic first-pass removal in metastasis of colon carcinoma cells.

N Mizuno1, Y Kato, Y Izumi, T Irimura, Y Sugiyama.   

Abstract

BACKGROUND/AIMS: It might be thought that colon carcinoma tends to metastasize to the liver because tumor cells leaving the primary colon tumor pass initially through the liver. Therefore we elucidated the kinetics of tumor cells in the body in order to understand the effect of the location of the liver on hepatic metastasis, that is to examine the hepatic first-pass effect of tumor cells.
METHODS: Based on a physiological kinetic model, we examined quantitatively the hepatic metastasis and hepatic distribution of KM12-H1X cells administered by different routes.
RESULTS: Both the number and incidence of colonies of hepatic metastasis were much greater after intrasplenic injection than after intravenous injection. The distribution of radioactivity to the liver after intrasplenic injection of [3H] thymidine-labeled cells was also much higher than that after intravenous injection. The number of colonies of hepatic metastasis correlated well with the area under the curve of the distributed amount of the tumor cells in the liver, regardless of the injection route; the correlation line was identical for each injection route.
CONCLUSIONS: These results suggest that the hepatic first-pass effect is an important factor for the hepatic metastasis and that the cumulative number of tumor cells distributed in the liver is a determining factor for the degree of metastasis. Mathematical analysis based on a physiological model also suggests that hepatic metastasis depends on hepatic first-pass trapping of tumor cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9625323     DOI: 10.1016/s0168-8278(98)80238-9

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  11 in total

1.  Liver resection for liver metastases from nondigestive endocrine cancer: extrahepatic disease burden defines outcome.

Authors:  Andreas Andreou; Antoine Brouquet; Kishore G S Bharathy; Nancy D Perrier; Eddie K Abdalla; Steven A Curley; Matthias Glanemann; Daniel Seehofer; Peter Neuhaus; Jean-Nicolas Vauthey; Thomas A Aloia
Journal:  Surgery       Date:  2012-02-04       Impact factor: 3.982

2.  Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma.

Authors:  Jürgen Weitz; Leslie H Blumgart; Yuman Fong; William R Jarnagin; Michael D'Angelica; Lawrence E Harrison; Ronald P DeMatteo
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

3.  Combined resection of colorectal hepatic-pulmonary metastases shows improved outcome over chemotherapy alone.

Authors:  Georgios Meimarakis; Martin Angele; Claudius Conrad; Rolf Schauer; Rolf Weidenhagen; Alexander Crispin; Clemens Giessen; Gerhard Preissler; Max Wiedemann; Karl-Walter Jauch; Volker Heinemann; Sebastian Stintzing; Rudolf A Hatz; Hauke Winter
Journal:  Langenbecks Arch Surg       Date:  2013-01-13       Impact factor: 3.445

4.  Fluorescence Labeling of Circulating Tumor Cells with a Folate Receptor-Targeted Molecular Probe for Diffuse In Vivo Flow Cytometry.

Authors:  Roshani A Patil; Madduri Srinivasarao; Mansoor M Amiji; Philip S Low; Mark Niedre
Journal:  Mol Imaging Biol       Date:  2020-10       Impact factor: 3.488

5.  Colorectal cancer metastasis: in the surgeon's hands?

Authors:  Gary Atkin; Abhay Chopada; Ian Mitchell
Journal:  Int Semin Surg Oncol       Date:  2005-02-24

6.  A High Circulating Tumor Cell Count in Portal Vein Predicts Liver Metastasis From Periampullary or Pancreatic Cancer: A High Portal Venous CTC Count Predicts Liver Metastases.

Authors:  Yu Wen Tien; Hsun-Chuan Kuo; Be-Ing Ho; Ming-Chu Chang; Yu-Ting Chang; Mei-Fang Cheng; Huai-Lu Chen; Ting-Yung Liang; Chien-Fang Wang; Chia-Yi Huang; Jin-Yuh Shew; Ying Chih Chang; Eva Yhp Lee; Wen-Hwa Lee
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

7.  Endoscopic Ultrasound-Guided Portal Pressure Measurement and Interventions.

Authors:  Jason B Samarasena; Kenneth J Chang
Journal:  Clin Endosc       Date:  2018-05-31

Review 8.  EUS-guided portal vein sampling.

Authors:  Christopher G Chapman; Irving Waxman
Journal:  Endosc Ultrasound       Date:  2018 Jul-Aug       Impact factor: 5.628

9.  Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment.

Authors:  Lao H Saal; Lisa Rydén; Daniel Förnvik; Kristina E Aaltonen; Yilun Chen; Anthony M George; Christian Brueffer; Robert Rigo; Niklas Loman
Journal:  Breast Cancer Res Treat       Date:  2019-06-24       Impact factor: 4.872

10.  Rapid evolution and biogeographic spread in a colorectal cancer.

Authors:  Joao M Alves; Sonia Prado-López; José Manuel Cameselle-Teijeiro; David Posada
Journal:  Nat Commun       Date:  2019-11-13       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.